83 related articles for article (PubMed ID: 29599336)
1. Glycine Is a Predictor for a Suppressive Effect of Fucoxanthinol on Colonosphere Formation Under Hypoxia.
Terasaki M; Ogawa Y; Endo T; Maeda H; Hamada J; Osada K; Miyashita K; Mutoh M
Anticancer Res; 2018 Apr; 38(4):2169-2179. PubMed ID: 29599336
[TBL] [Abstract][Full Text] [Related]
2. Glycine and succinic acid are effective indicators of the suppression of epithelial-mesenchymal transition by fucoxanthinol in colorectal cancer stem-like cells.
Terasaki M; Mima M; Kudoh S; Endo T; Maeda H; Hamada J; Osada K; Miyashita K; Mutoh M
Oncol Rep; 2018 Jul; 40(1):414-424. PubMed ID: 29693702
[TBL] [Abstract][Full Text] [Related]
3. Fucoxanthin administration delays occurrence of tumors in xenograft mice by colonospheres, with an anti-tumor predictor of glycine.
Terasaki M; Matsumoto N; Hashimoto R; Endo T; Maeda H; Hamada J; Osada K; Miyashita K; Mutoh M
J Clin Biochem Nutr; 2019 Jan; 64(1):52-58. PubMed ID: 30705512
[TBL] [Abstract][Full Text] [Related]
4. Effects of CLIC4 on Fucoxanthinol-Induced Apoptosis in Human Colorectal Cancer Cells.
Yokoyama R; Kojima H; Takai R; Ohta T; Maeda H; Miyashita K; Mutoh M; Terasaki M
Nutr Cancer; 2021; 73(5):889-898. PubMed ID: 33703973
[TBL] [Abstract][Full Text] [Related]
5. A Marine Carotenoid of Fucoxanthinol Accelerates the Growth of Human Pancreatic Cancer PANC-1 Cells.
Terasaki M; Takahashi S; Nishimura R; Kubota A; Kojima H; Ohta T; Hamada J; Kuramitsu Y; Maeda H; Miyashita K; Takahashi M; Mutoh M
Nutr Cancer; 2022; 74(1):357-371. PubMed ID: 33590779
[TBL] [Abstract][Full Text] [Related]
6. Maintenance of Clonogenic KIT(+) Human Colon Tumor Cells Requires Secretion of Stem Cell Factor by Differentiated Tumor Cells.
Fatrai S; van Schelven SJ; Ubink I; Govaert KM; Raats D; Koster J; Verheem A; Borel Rinkes IH; Kranenburg O
Gastroenterology; 2015 Sep; 149(3):692-704. PubMed ID: 25962936
[TBL] [Abstract][Full Text] [Related]
7. Requirement of CLIC4 Expression in Human Colorectal Cancer Cells for Sensitivity to Growth Inhibition by Fucoxanthinol.
Yokoyama R; Kushibiki A; Yamada S; Kubota A; Kojima H; Ohta T; Hamada J; Maeda H; Mutoh M; Terasaki M
Cancer Genomics Proteomics; 2022; 19(4):428-444. PubMed ID: 35732323
[TBL] [Abstract][Full Text] [Related]
8. A Fucoxanthinol Induces Apoptosis in a Pancreatic Intraepithelial Neoplasia Cell.
Terasaki M; Inoue T; Murase W; Kubota A; Kojima H; Kojoma M; Ohta T; Maeda H; Miyashita K; Mutoh M; Takahashi M
Cancer Genomics Proteomics; 2021; 18(2):133-146. PubMed ID: 33608310
[TBL] [Abstract][Full Text] [Related]
9. Effect of Fucoxanthinol on Pancreatic Ductal Adenocarcinoma Cells from an
Terasaki M; Nishizaka Y; Murase W; Kubota A; Kojima H; Kojoma M; Tanaka T; Maeda H; Miyashita K; Mutoh M; Takahashi M
Cancer Genomics Proteomics; 2021; 18(3 Suppl):407-423. PubMed ID: 33994364
[TBL] [Abstract][Full Text] [Related]
10. A marine bio-functional lipid, fucoxanthinol, attenuates human colorectal cancer stem-like cell tumorigenicity and sphere formation.
Terasaki M; Maeda H; Miyashita K; Tanaka T; Miyamoto S; Mutoh M
J Clin Biochem Nutr; 2017 Jul; 61(1):25-32. PubMed ID: 28751806
[TBL] [Abstract][Full Text] [Related]
11. Fucoxanthin and its deacetylated product, fucoxanthinol, induce apoptosis of primary effusion lymphomas.
Yamamoto K; Ishikawa C; Katano H; Yasumoto T; Mori N
Cancer Lett; 2011 Jan; 300(2):225-34. PubMed ID: 21078541
[TBL] [Abstract][Full Text] [Related]
12. Anti-neoplastic effects of fucoxanthin and its deacetylated product, fucoxanthinol, on Burkitt's and Hodgkin's lymphoma cells.
Tafuku S; Ishikawa C; Yasumoto T; Mori N
Oncol Rep; 2012 Oct; 28(4):1512-8. PubMed ID: 22859062
[TBL] [Abstract][Full Text] [Related]
13. Comparative effects between fucoxanthinol and its precursor fucoxanthin on viability and apoptosis of breast cancer cell lines MCF-7 and MDA-MB-231.
Rwigemera A; Mamelona J; Martin LJ
Anticancer Res; 2015 Jan; 35(1):207-19. PubMed ID: 25550553
[TBL] [Abstract][Full Text] [Related]
14. Ursolic acid inhibits the proliferation of human ovarian cancer stem-like cells through epithelial-mesenchymal transition.
Zhang J; Wang W; Qian L; Zhang Q; Lai D; Qi C
Oncol Rep; 2015 Nov; 34(5):2375-84. PubMed ID: 26323892
[TBL] [Abstract][Full Text] [Related]
15. Fucoxanthinol, Metabolite of Fucoxanthin, Improves Obesity-Induced Inflammation in Adipocyte Cells.
Maeda H; Kanno S; Kodate M; Hosokawa M; Miyashita K
Mar Drugs; 2015 Aug; 13(8):4799-813. PubMed ID: 26248075
[TBL] [Abstract][Full Text] [Related]
16. Characterization of sphere-propagating cells with stem-like properties from DU145 prostate cancer cells.
Rybak AP; He L; Kapoor A; Cutz JC; Tang D
Biochim Biophys Acta; 2011 May; 1813(5):683-94. PubMed ID: 21277911
[TBL] [Abstract][Full Text] [Related]
17. Fucoxanthin and its metabolite, fucoxanthinol, suppress adipocyte differentiation in 3T3-L1 cells.
Maeda H; Hosokawa M; Sashima T; Takahashi N; Kawada T; Miyashita K
Int J Mol Med; 2006 Jul; 18(1):147-52. PubMed ID: 16786166
[TBL] [Abstract][Full Text] [Related]
18. Different Effects of BORIS/CTCFL on Stemness Gene Expression, Sphere Formation and Cell Survival in Epithelial Cancer Stem Cells.
Alberti L; Losi L; Leyvraz S; Benhattar J
PLoS One; 2015; 10(7):e0132977. PubMed ID: 26185996
[TBL] [Abstract][Full Text] [Related]
19. Fucoxanthinol attenuates oxidative stress-induced atrophy and loss in myotubes and reduces the triacylglycerol content in mature adipocytes.
Yoshikawa M; Hosokawa M; Miyashita K; Fujita T; Nishino H; Hashimoto T
Mol Biol Rep; 2020 Apr; 47(4):2703-2711. PubMed ID: 32180086
[TBL] [Abstract][Full Text] [Related]
20. Fucoxanthin and Its Metabolite Fucoxanthinol in Cancer Prevention and Treatment.
Martin LJ
Mar Drugs; 2015 Jul; 13(8):4784-98. PubMed ID: 26264004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]